It’s the insulin, stupid: How drug pricing’s simplest case study became a top issue for 2020 Democrats

Lev Facher of Stat News –

Presidential candidates can’t stop talking about insulin.

At a campaign stop in Iowa, Sen. Amy Klobuchar retold the now-familiar story of Alec Smith, whose highly publicized death from insulin rationing in 2017 sparked nationwide outrage. Sen. Elizabeth Warren, who has vowed to lower the drug’s price on her first day in office, lambasted Eli Lilly, one of just three U.S. insulin manufacturers, at an Iowa rally the day before.

And since July, when Sen. Bernie Sanders joined a highly publicized “insulin caravan” seeking cheaper prices in Canada, he has flooded Iowa with television ads that picture him brandishing an insulin vial in outrage.


About Radnor Reports

Ken Feltman is past-president of the International Association of Political Consultants and the American League of Lobbyists. He is retired chairman of Radnor Inc., an international political consulting and government relations firm in Washington, D.C. Known as a coalition builder, he has participated in election campaigns and legislative efforts in the United States and several other countries.
This entry was posted in 2020 election, Democrats, Healthcare. Bookmark the permalink.